Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy

PURPOSE: To report the clinical course of a woman treated with intravitreal bevacizumab during pregnancy. CASE REPORT: A 27-year-old female with poorly controlled diabetes and a history of two previous miscarriage was referred to our hospital with sudden deterioration in visual acuity (VA) in her ri...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Drug Assess
Hlavní autoři: Kianersi, Farzan, Ghanbari, Heshmatollah, Naderi Beni, Zahra, Naderi Beni, Afsaneh
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2021
Témata:
Pregnancy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7971320/
https://ncbi.nlm.nih.gov/pubmed/33796345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2020.1847926
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky